Nektar Therapeutics (NKTR)

$90.15 $-2.39 (-2.58%)

  • Last Price:
    $90.15
  • Previous Close:
    $92.54
  • Change:
    $-2.39 (-2.58%)
  • Open:
    $92.55
  • Volume:
    1,724,753
  • Day's Range:
    $89.92 - $92.55
  • Dividend Yield:
    0%
  • 52-week Range:
    $111.36 - $17.33
  • P-E:
    0
  • EPS:
    $-0.65

Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company is researching and developing drugs for treating cancer, auto-immune disease and chronic pain.

It seems we can’t find what you’re looking for. Perhaps searching can help.